Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could an ancient remedy cut early deaths in leukemia?

NCT ID NCT07503730

First seen Apr 01, 2026 · Last updated Jun 13, 2026 · Updated 14 times

Summary

This study tests whether giving a Chinese herbal medicine called Realgar-Indigo naturalis formula (RIF) together with standard vitamin A therapy right away can lower the risk of early death in people with a fast-growing blood cancer called acute promyelocytic leukemia (APL). About 224 adults with suspected APL will be randomly assigned to get either RIF plus standard care or standard care alone before their diagnosis is confirmed. The goal is to see if early RIF reduces deaths within the first 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • First Affiliated Hospital of Xi'an Jiaotong University

    RECRUITING

    Xi'an, Shaanxi, 710061, China

Conditions

The condition(s) this trial relates to.

atrichia with papular lesions

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.